Elanco Animal Health Incorporated (ELAN) Earnings Call Analysis
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
Elanco (ELAN) Q1 2026: Innovation Revenue Surges $287M, Raising Full-Year Guidance and Margin Ambitions
June 16, 2026
-
Elanco (ELAN) Q2 2025: Innovation Revenue Raised $60M as Pet Health Outpaces Base Trends
June 16, 2026
-
Elanco (ELAN) Q3 2025: Innovation Revenue Raised $100M, Margin Expansion in Sight
June 16, 2026
-
Elanco (ELAN) Q4 2025: Innovation Revenue Surges $892M as Big Six Drive Double-Digit Share Gains
June 15, 2026
-
Elanco (ELAN) Q1 2025: $198M Innovation Revenue Powers 4% Organic Growth and Accelerates Deleveraging
July 06, 2025